February 16, 2021
A natural product to fight symptoms related to COVID-19
The Montreal Heart Institute (MHI) is launching a new clinical trial to evaluate the effect of hesperidin on symptoms related to COVID-19. This flavonoid naturally found in citrus fruits has distinct properties that may reduce the entry and replication of the SARS-CoV2 virus in the body along with the modulation of inflammatory mediators, thus potentially reducing symptoms and prevent complications from the disease.
January 29, 2021
Due to an outbreak in the surgical continuum, caregiver visits are suspended indefinitely.
Caregivers will not be able to come to the surgical intensive care unit (3rd east) and the surgical unit (3rd center) until further notice.
In exceptional situations or for humanitarian reasons (eg: end of life), a caregiver may be authorized, with the agreement of the care unit.
January 27, 2021
UPDATE: COLCORONA study manuscript is now available in the public domain.
On January 22, 2021, the Montreal Heart Institute announced positive results from COLCORONA trial. These results showed that colchicine is the only effective oral medication for treating non-hospitalized patients.